Wang, Zixia
Hao, Chunyue
Huang, Jingjing
Zhuang, Qinghui
Zhan, Bin
Zhu, Xinping
Funding for this research was provided by:
Natural Science Foundation of Beijing Municipality (7162017)
National Natural Science Foundation of China (81672042)
Article History
Received: 7 September 2018
Accepted: 5 December 2018
First Online: 27 December 2018
Ethics approval and consent to participate
: Normal human serum (NHS) was selected from healthy human volunteers with written consent forms. The project was approved by the Institutional Review Board (IRB) of Capital Medical University (approval number: 2016SY01). Human C1q-deficient serum (C1q D) was purchased from Merck (Merck Darmstadt, Germany).
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.